Clinical Trial Update: Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Acalabrutinib is being studied as maintenance therapy in a Phase 1/2 trial for large B-cell lymphomas, including diffuse large B-cell lymphoma, high-grade B-cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma
• Transformed Lymphoma

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING